Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The one-two punch (of CAR T cells).
Shah NN. Shah NN. Blood. 2020 Jan 30;135(5):303-304. doi: 10.1182/blood.2019004272. Blood. 2020. PMID: 31999814 Free PMC article.
CAR T cells better than BiTEs.
Molina JC, Shah NN. Molina JC, et al. Among authors: shah nn. Blood Adv. 2021 Jan 26;5(2):602-606. doi: 10.1182/bloodadvances.2020003554. Blood Adv. 2021. PMID: 33496756 Free PMC article. No abstract available.
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Lichtenstein DA, Schischlik F, Shao L, Steinberg SM, Yates B, Wang HW, Wang Y, Inglefield J, Dulau-Florea A, Ceppi F, Hermida LC, Stringaris K, Dunham K, Homan P, Jailwala P, Mirazee J, Robinson W, Chisholm KM, Yuan C, Stetler-Stevenson M, Ombrello AK, Jin J, Fry TJ, Taylor N, Highfill SL, Jin P, Gardner RA, Shalabi H, Ruppin E, Stroncek DF, Shah NN. Lichtenstein DA, et al. Among authors: shah nn. Blood. 2021 Dec 16;138(24):2469-2484. doi: 10.1182/blood.2021011898. Blood. 2021. PMID: 34525183 Free PMC article. Clinical Trial.
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Mikkilineni L, Yates B, Steinberg SM, Shahani SA, Molina JC, Palmore T, Lee DW, Kaplan RN, Mackall CL, Fry TJ, Gea-Banacloche J, Jerussi T, Nussenblatt V, Kochenderfer JN, Shah NN. Mikkilineni L, et al. Among authors: shah nn. Blood Adv. 2021 Dec 14;5(23):5312-5322. doi: 10.1182/bloodadvances.2021004896. Blood Adv. 2021. PMID: 34619768 Free PMC article. Review.
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy.
Holland EM, Yates B, Ling A, Yuan CM, Wang HW, Stetler-Stevenson M, LaLoggia M, Molina JC, Lichtenstein DA, Lee DW, Ligon JA, Shalabi H, Ahlman MA, Shah NN. Holland EM, et al. Among authors: shah nn. Blood Adv. 2022 Apr 12;6(7):2167-2182. doi: 10.1182/bloodadvances.2021006035. Blood Adv. 2022. PMID: 34920453 Free PMC article.
Anakinra utilization in refractory pediatric CAR T-cell associated toxicities.
Diorio C, Vatsayan A, Talleur AC, Annesley C, Jaroscak JJ, Shalabi H, Ombrello AK, Hudspeth M, Maude SL, Gardner RA, Shah NN. Diorio C, et al. Among authors: shah nn. Blood Adv. 2022 Jun 14;6(11):3398-3403. doi: 10.1182/bloodadvances.2022006983. Blood Adv. 2022. PMID: 35395068 Free PMC article. No abstract available.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Lamble AJ, Myers RM, Taraseviciute A, John S, Yates B, Steinberg SM, Sheppard J, Kovach AE, Wood B, Borowitz MJ, Stetler-Stevenson M, Yuan CM, Pillai V, Foley T, Chung P, Chen L, Lee DW, Annesley C, DiNofia A, Grupp SA, Verneris MR, Gore L, Laetsch TW, Bhojwani D, Brown PA, Pulsipher MA, Rheingold SR, Gardner RA, Shah NN. Lamble AJ, et al. Among authors: shah nn. Blood Adv. 2023 Feb 28;7(4):575-585. doi: 10.1182/bloodadvances.2022007423. Blood Adv. 2023. PMID: 35482927 Free PMC article.
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Shalabi H, Qin H, Su A, Yates B, Wolters PL, Steinberg SM, Ligon JA, Silbert S, DéDé K, Benzaoui M, Goldberg S, Achar S, Schneider D, Shahani SA, Little L, Foley T, Molina JC, Panch S, Mackall CL, Lee DW, Chien CD, Pouzolles M, Ahlman M, Yuan CM, Wang HW, Wang Y, Inglefield J, Toledo-Tamula MA, Martin S, Highfill SL, Altan-Bonnet G, Stroncek D, Fry TJ, Taylor N, Shah NN. Shalabi H, et al. Among authors: shah nn. Blood. 2022 Aug 4;140(5):451-463. doi: 10.1182/blood.2022015795. Blood. 2022. PMID: 35605184 Free PMC article. Clinical Trial.
466 results